211 related articles for article (PubMed ID: 25663018)
1. Recent progress in designing inhibitors that target the drug-resistant M2 proton channels from the influenza A viruses.
Wang J; Li F; Ma C
Biopolymers; 2015 Jul; 104(4):291-309. PubMed ID: 25663018
[TBL] [Abstract][Full Text] [Related]
2. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
Moorthy NS; Poongavanam V; Pratheepa V
Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Potent Antivirals against Amantadine-Resistant Influenza A Viruses by Targeting the M2-S31N Proton Channel.
Li F; Ma C; Hu Y; Wang Y; Wang J
ACS Infect Dis; 2016 Oct; 2(10):726-733. PubMed ID: 27657178
[TBL] [Abstract][Full Text] [Related]
4. Structural and energetic analysis of drug inhibition of the influenza A M2 proton channel.
Gu RX; Liu LA; Wei DQ
Trends Pharmacol Sci; 2013 Oct; 34(10):571-80. PubMed ID: 24011996
[TBL] [Abstract][Full Text] [Related]
5. Put a cork in it: Plugging the M2 viral ion channel to sink influenza.
Jalily PH; Duncan MC; Fedida D; Wang J; Tietjen I
Antiviral Res; 2020 Jun; 178():104780. PubMed ID: 32229237
[TBL] [Abstract][Full Text] [Related]
6. Discovery of M2 channel blockers targeting the drug-resistant double mutants M2-S31N/L26I and M2-S31N/V27A from the influenza A viruses.
Musharrafieh R; Ma C; Wang J
Eur J Pharm Sci; 2020 Jan; 141():105124. PubMed ID: 31669761
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Highly Potent Inhibitors Targeting the Predominant Drug-Resistant S31N Mutant of the Influenza A Virus M2 Proton Channel.
Li F; Ma C; DeGrado WF; Wang J
J Med Chem; 2016 Feb; 59(3):1207-16. PubMed ID: 26771709
[TBL] [Abstract][Full Text] [Related]
8. Expeditious Lead Optimization of Isoxazole-Containing Influenza A Virus M2-S31N Inhibitors Using the Suzuki-Miyaura Cross-Coupling Reaction.
Li F; Hu Y; Wang Y; Ma C; Wang J
J Med Chem; 2017 Feb; 60(4):1580-1590. PubMed ID: 28182419
[TBL] [Abstract][Full Text] [Related]
9. Novel spirothiazamenthane inhibitors of the influenza A M2 proton channel.
Arns S; Balgi AD; Shimizu Y; Pfeifer TA; Kumar N; Shidmoossavee FS; Sun S; Tai SS; Agafitei O; Jaquith JB; Bourque E; Niikura M; Roberge M
Eur J Med Chem; 2016 Sep; 120():64-73. PubMed ID: 27187859
[TBL] [Abstract][Full Text] [Related]
10. Investigation into adamantane-based M2 inhibitors with FB-QSAR.
Wei H; Wang CH; Du QS; Meng J; Chou KC
Med Chem; 2009 Jul; 5(4):305-17. PubMed ID: 19689387
[TBL] [Abstract][Full Text] [Related]
11. Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations.
Dong G; Peng C; Luo J; Wang C; Han L; Wu B; Ji G; He H
PLoS One; 2015; 10(3):e0119115. PubMed ID: 25768797
[TBL] [Abstract][Full Text] [Related]
12. Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus.
Duncan MC; Onguéné PA; Kihara I; Nebangwa DN; Naidu ME; Williams DE; Balgi AD; Andrae-Marobela K; Roberge M; Andersen RJ; Niikura M; Ntie-Kang F; Tietjen I
Molecules; 2020 Jun; 25(12):. PubMed ID: 32599753
[TBL] [Abstract][Full Text] [Related]
13. Antivirals for influenza: historical perspectives and lessons learned.
Hayden FG
Antiviral Res; 2006 Sep; 71(2-3):372-8. PubMed ID: 16815563
[TBL] [Abstract][Full Text] [Related]
14. Tackling Influenza A virus by M2 ion channel blockers: Latest progress and limitations.
Kumar G; Sakharam KA
Eur J Med Chem; 2024 Mar; 267():116172. PubMed ID: 38330869
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Pharmacokinetic Optimizations of AM2-S31N Channel Blockers Led to the Discovery of Slow-Binding Inhibitors with Potent Antiviral Activity against Drug-Resistant Influenza A Viruses.
Wang Y; Hu Y; Xu S; Zhang Y; Musharrafieh R; Hau RK; Ma C; Wang J
J Med Chem; 2018 Feb; 61(3):1074-1085. PubMed ID: 29341607
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in computational studies on influenza a virus M2 proton channel.
Wang JF; Chou KC
Mini Rev Med Chem; 2012 Sep; 12(10):971-8. PubMed ID: 22420575
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors.
Zhao X; Jie Y; Rosenberg MR; Wan J; Zeng S; Cui W; Xiao Y; Li Z; Tu Z; Casarotto MG; Hu W
Antiviral Res; 2012 Nov; 96(2):91-9. PubMed ID: 22982118
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene Amiloride.
Jalily PH; Eldstrom J; Miller SC; Kwan DC; Tai SS; Chou D; Niikura M; Tietjen I; Fedida D
Mol Pharmacol; 2016 Aug; 90(2):80-95. PubMed ID: 27193582
[TBL] [Abstract][Full Text] [Related]
19. Antivirals--current trends in fighting influenza.
Król E; Rychłowska M; Szewczyk B
Acta Biochim Pol; 2014; 61(3):495-504. PubMed ID: 25180220
[TBL] [Abstract][Full Text] [Related]
20. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
Nguyen HT; Fry AM; Gubareva LV
Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
